A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 19, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMTX SEC filings page.
Aemetis, Inc. (AMTX) reported $248.8M in revenue over the twelve months to Sep 30, 2026, up 23.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Aemetis remains loss-making and heavily financed, with FY2025 operating cash flow barely positive while capital spending and interest stayed substantial.
FY2025 operating cash flow turned positive at$3.3M even as the company reported a net loss of$77.0M , showing cash generation and reported earnings diverged. But capital expenditures reached$26.0M , or796.9% of operating cash flow, leaving reinvestment unfunded by internal cash generation.
Balance-sheet strain is structural: liabilities reached
Revenue contracted
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Aemetis, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Aemetis, Inc. held $4.9M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations generated $3.3M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Aemetis, Inc. scores 87/100 among other emerging companies.
Dilution ranks emerging companies on the yearly rate at which their shares outstanding grew across the last three fiscal years (the last two where the earliest reports none), a slower rise ranking higher because each round of funding spreads the same business across more owners. Aemetis, Inc. scores 34/100 on it among other emerging companies.
Not available for Aemetis, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Revenue Progress ranks emerging companies on the yearly rate at which their revenue compounded across the last three fiscal years (the last two where the earliest reports none), counted in the currency each company reports in. Aemetis, Inc. scores 81/100 on it among other emerging companies.
Not available for Aemetis, Inc., so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Aemetis, Inc.'s cash, cash equivalents and investments came to $4.9M at the end of fiscal year 2025, against $566.7M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Aemetis, Inc. scores 2/100 among other emerging companies.
Aemetis, Inc. scores -4.68, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $639.9M against total assets of $259.8M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Aemetis, Inc. passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
Aemetis, Inc. reported a net loss of $77.0M while generating $3.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Aemetis, Inc. reported an operating loss of $37.2M against $52.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Aemetis, Inc. generated $88.2M in revenue in Q3 2026. This represents an increase of 48.9% from the same quarter a year earlier. Against the prior quarter it is up 40.6%.
Aemetis, Inc.'s EBITDA was $23.4M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is up 181.7%.
Aemetis, Inc. reported $5.2M in net income in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Aemetis, Inc. earned -$0.02 per diluted share (EPS) in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Cash & Balance Sheet
Aemetis, Inc. generated $1.7M in free cash flow in Q3 2026, representing cash available after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Aemetis, Inc. held $3.4M in cash against $58.5M in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Aemetis, Inc.'s gross margin was 33.4% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 33.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.9 percentage points.
Aemetis, Inc.'s operating margin was 23.6% in Q3 2026, reflecting core business profitability. This is up 38.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.4 percentage points.
Aemetis, Inc.'s net profit margin was 5.9% in Q3 2026, showing the share of revenue converted to profit. This is up 46.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 20.9 percentage points.
Not reported for Q3 2026.
Capital Allocation
Aemetis, Inc. invested $20.2M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 394.4% from the same quarter a year earlier. Against the prior quarter it is up 137.0%.
Not reported for Q3 2026.
Not reported for Q3 2026.
AMTX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.2M+48.9% | $62.7M+20.0% | $54.6M+27.4% | $43.3M-7.9% | $59.2M-27.3% | $52.2M-21.5% | $42.9M-41.0% | $47.0M-33.6% |
| Cost of Revenue | $58.7M-1.0% | $49.2M-11.5% | $51.9M+8.1% | $45.9M-6.3% | $59.2M-23.6% | $55.6M-18.7% | $48.0M-34.5% | $49.0M-29.8% |
| Gross Profit | $29.5Mn/m | $13.5Mn/m | $2.8Mn/m | -$2.6Mn/m | -$58K-101.5% | -$3.4Mn/m | -$5.1Mn/m | -$2.0M-336.1% |
| SG&A Expenses | $8.6M+2.0% | $7.7M+5.8% | $9.1M-13.2% | $10.2M-10.8% | $8.4M+9.0% | $7.3M-38.0% | $10.5M+18.4% | $11.4M+16.4% |
| Operating Income | $20.9Mn/m | $5.8Mn/m | -$6.3Mn/m | -$2.5Mn/m | -$8.5Mn/m | -$10.7Mn/m | -$15.6Mn/m | -$13.5Mn/m |
| EBITDA | $23.4Mn/m | $8.3Mn/m | -$3.8Mn/m | $99Kn/m | -$6.2Mn/m | -$8.3Mn/m | -$13.2Mn/m | -$11.2Mn/m |
| Interest Expense | $14.5M+12.3% | $13.7M+10.8% | $14.4M+5.0% | $13.9M+10.3% | $12.9M+10.2% | $12.3M+5.2% | $13.7M+30.2% | $12.6M+18.5% |
| Income Tax | $2K-66.7% | $0n/m | -$131Kn/m | -$11.4Mn/m | $6K-97.8% | -$529K-237.4% | -$6.8M-872.6% | -$12.4M-1740.5% |
| Net Income | $5.2Mn/m | -$9.4Mn/m | -$21.7Mn/m | -$5.3Mn/m | -$23.7Mn/m | -$23.4Mn/m | -$24.5Mn/m | -$16.2Mn/m |
| EPS (Basic) | $0.07n/m | -$0.13n/m | -$0.33n/m | -$0.04 | -$0.37n/m | -$0.41n/m | -$0.47n/m | -$0.31n/m |
| EPS (Diluted) | -$0.02n/m | -$0.13n/m | -$0.33n/m | -$0.04 | -$0.37n/m | -$0.41n/m | -$0.47n/m | -$0.31n/m |
| Diluted Shares (Avg) | 73M+13.8% | 71M+22.9% | 67M+27.0% | N/A | 64M+34.9% | 58M+29.9% | 53M+25.5% | N/A |
Not reported in any period shown, so not listed: R&D Expenses.
AMTX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $312.0M+29.4% | $289.2M+20.5% | $270.3M+4.0% | $259.8M+0.2% | $241.1M-7.0% | $240.0M-7.4% | $259.8M+0.2% | $259.3M+6.5% |
| Current Assets | $29.1M+87.3% | $33.0M+64.3% | $34.7M+21.7% | $26.9M-39.9% | $15.6M-55.4% | $20.1M-15.8% | $28.5M-13.5% | $44.7M+22.8% |
| Cash & Equivalents | $3.4M-39.8% | $973K-40.9% | $4.8M+861.3% | $4.9M+445.0% | $5.6M+1786.5% | $1.6M+603.0% | $499K-69.4% | $898K-66.3% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Inventory | $12.9M+170.7% | $13.6M+10.2% | $10.4M-54.7% | $11.6M-54.3% | $4.8M-75.9% | $12.4M+20.8% | $22.9M+43.2% | $25.4M+39.1% |
| Accounts Receivable | $4.4M+175.0% | $2.3M-14.8% | $6.6M+560.0% | $500K-72.2% | $1.6M | $2.7M | $1.0M-44.4% | $1.8M-79.1% |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $626.2M+14.7% | $611.3M+15.5% | $591.5M+9.4% | $566.7M+8.3% | $546.0M+5.4% | $529.3M+4.1% | $540.5M+10.0% | $523.2M+13.7% |
| Current Liabilities | $439.8M+28.1% | $415.0M+28.9% | $396.2M+126.9% | $371.3M+157.9% | $343.4M+159.6% | $321.9M+166.4% | $174.6M+48.1% | $144.0M+70.6% |
| Non-Current Liabilities | $186.4M-8.0% | $196.3M-5.3% | $195.2M-44.0% | $195.4M-48.5% | $202.6M-45.8% | $207.3M-42.4% | $348.6M-2.2% | $379.3M+0.9% |
| Long-Term Debt | $58.5M-12.4% | $61.7M-16.2% | $62.0M-71.4% | $63.9M-74.2% | $66.8M-72.7% | $73.6M-68.6% | $216.7M-7.5% | $247.5M-3.9% |
| Total Equity | -$314.2Mn/m | -$322.1Mn/m | -$321.1Mn/m | -$306.8Mn/m | -$304.9Mn/m | -$289.3Mn/m | -$280.7Mn/m | -$263.9Mn/m |
| Retained Earnings | -$665.8Mn/m | -$671.0Mn/m | -$661.7Mn/m | -$639.9Mn/m | -$634.6Mn/m | -$610.9Mn/m | -$587.5Mn/m | -$562.9Mn/m |
Not reported in any period shown, so not listed: Goodwill.
AMTX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $22.0M+615.5% | -$1.9Mn/m | -$10.6M-6698.1% | $5.8Mn/m | $3.1Mn/m | -$5.7Mn/m | $160Kn/m | -$12.6M-137.0% |
| Depreciation & Amortization | $2.6M+9.5% | $2.5M+6.4% | $2.5M+5.7% | $2.6M+14.2% | $2.4M+1.8% | $2.4M+14.3% | $2.4M+30.4% | $2.3M+26.1% |
| Stock-Based Compensation | $1.2M-13.9% | $1.1M-21.8% | $1.7M-26.2% | N/A | $1.4M-30.1% | $1.4M-27.5% | $2.3M-22.3% | N/A |
| Capital Expenditures | $20.2M+394.4% | $8.5M+142.1% | $6.5M+258.8% | $16.6M+144.1% | $4.1M-8.9% | $3.5M-34.7% | $1.8M-49.1% | $6.8M-53.3% |
| Free Cash Flow | $1.7Mn/m | -$10.4Mn/m | -$17.1Mn/m | -$10.8Mn/m | -$1.0Mn/m | -$9.3Mn/m | -$1.7Mn/m | -$19.4M-199.6% |
| Investing Cash Flow | -$20.2Mn/m | -$8.5Mn/m | -$5.1Mn/m | -$16.6Mn/m | -$4.1Mn/m | -$3.1Mn/m | -$1.8Mn/m | -$3.7Mn/m |
| Financing Cash Flow | -$362K-107.1% | $7.1M-29.5% | $14.7M+1073.7% | $10.0M-40.5% | $5.1M-43.3% | $10.0M+23.0% | $1.3M-88.2% | $16.8Mn/m |
Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.
AMTX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.4%+33.5pp | 21.6%+28.0pp | 5.1%+16.9pp | -6.1%-1.7pp | -0.1%-4.9pp | -6.4%-3.7pp | -11.8%-11.0pp | -4.3%-5.6pp |
| Operating Margin | 23.6%+38.0pp | 9.2%+29.6pp | -11.6%+24.7pp | -5.7%+22.9pp | -14.4%-9.6pp | -20.4%0.0pp | -36.3%-23.2pp | -28.7%-16.0pp |
| Net Margin | 5.9%+46.0pp | -14.9%+29.8pp | -39.8%+17.4pp | -12.3%+22.2pp | -40.1%-18.1pp | -44.8%-0.9pp | -57.2%-23.8pp | -34.5%+1.5pp |
| Return on Assets | 1.7%+11.5pp | -3.2%+6.5pp | -8.0%+1.4pp | -2.1%+4.2pp | -9.8%-2.9pp | -9.8%+1.5pp | -9.4%-0.1pp | -6.3%+4.2pp |
| Current Ratio | 0.070.0x | 0.080.0x | 0.09-0.1x | 0.07-0.2x | 0.05-0.2x | 0.06-0.1x | 0.16-0.1x | 0.31-0.1x |
| Asset Turnover | 0.280.0x | 0.220.0x | 0.200.0x | 0.170.0x | 0.25-0.1x | 0.220.0x | 0.17-0.1x | 0.18-0.1x |
| FCF Margin | 2.0%+3.7pp | -16.6%+1.1pp | -31.3%-27.4pp | -24.9%+16.3pp | -1.7%+9.9pp | -17.7%-2.0pp | -3.9%+15.2pp | -41.2%-68.7pp |
Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, Liabilities-to-Equity.
Note: Shareholder equity is negative (-$306.8M), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.07), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Aemetis, Inc. AMTX | FY2025 | $197.6M | -$77.0M | -39.0% | $69.2M | 51/100 |
| Flexible Solutions International, Inc. FSI | FY2025 | $38.5M | $787K | 2.0% | $75.8M | 59/100 |
| 5E Advanced Materials, Inc. FEAM | FY2026 | N/A | -$42.9M | N/A | $76.9M | — |
| Northern Technologies International Corp. NTIC | FY2026 | $96.0M | -$703K | -0.7% | $71.5M | 47/100 |
| Future Fuel Corporation FF | FY2025 | $95.7M | -$49.4M | -51.6% | $131.6M | 34/100 |
| Montauk Renewables, Inc. MNTK | FY2025 | $176.4M | $1.7M | 1.0% | $163.7M | 30/100 |
Where Aemetis, Inc. Ranks
Frequently Asked Questions
Aemetis, Inc. (AMTX) reported $197.6M in total revenue for fiscal year 2025. This represents a -26.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Aemetis, Inc. (AMTX) revenue declined by 26.2% year-over-year, from $267.6M to $197.6M in fiscal year 2025.
No, Aemetis, Inc. (AMTX) reported a net loss of $31.2M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net loss of $77.0M, with a net profit margin of -39.0%.
Aemetis, Inc. (AMTX) had EBITDA of -$27.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2025, Aemetis, Inc. (AMTX) had $4.9M in cash and equivalents against $63.9M in long-term debt.
Aemetis, Inc. (AMTX) had a gross margin of -0.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Aemetis, Inc. (AMTX) had an operating margin of -18.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Aemetis, Inc. (AMTX) had a net profit margin of -39.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Aemetis, Inc. (AMTX) recorded an outflow of $22.7M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Aemetis, Inc. (AMTX) generated $3.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Aemetis, Inc. (AMTX) had $259.8M in total assets as of fiscal year 2025, including both current and long-term assets.
Aemetis, Inc. (AMTX) invested $26.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Aemetis, Inc. (AMTX) had a current ratio of 0.07 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Aemetis, Inc. (AMTX) had a return on assets of -29.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Aemetis, Inc. (AMTX) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to September 30, 2026). The market capitalization is $69.2M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Aemetis, Inc. (AMTX) trades at 0.3x sales, its market capitalization divided by $248.8M revenue, trailing 12 months to September 30, 2026. The market capitalization is $69.2M as of Nov 19, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Aemetis, Inc. (AMTX) has negative shareholder equity of -$306.8M as of fiscal year 2025, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Aemetis, Inc. (AMTX) has an Altman Z-Score of -4.68, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Aemetis, Inc. (AMTX) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Aemetis, Inc. (AMTX) reported a net loss of $77.0M while generating $3.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Aemetis, Inc. (AMTX) reported an operating loss of $37.2M against $52.9M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Aemetis, Inc. (AMTX) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Aemetis, Inc. it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.